Pretreatment eosinophil counts (PEC) in metastatic urothelial carcinoma (mUC) treated with anti-PD1/PD-L1 checkpoint inhibitors (CPI) Meeting Abstract


Authors: Mota, J. M.; Teo, M. Y.; Whiting, K.; Ostrovnaya, I.; Li, H.; Lee, C. H.; Funt, S. A.; Callahan, M. K.; Iyer, G.; Bajorin, D. F.; Rosenberg, J. E.
Abstract Title: Pretreatment eosinophil counts (PEC) in metastatic urothelial carcinoma (mUC) treated with anti-PD1/PD-L1 checkpoint inhibitors (CPI)
Meeting Title: 55th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 15 Suppl.
Meeting Dates: 2019 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-05-20
Language: English
ACCESSION: WOS:000487345801468
DOI: 10.1200/JCO.2019.37.15_suppl.e16035
PROVIDER: wos
Notes: Meeting Abstract: e16035 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dean Bajorin
    660 Bajorin
  2. Gopakumar Vasudeva Iyer
    351 Iyer
  3. Margaret Kathleen Callahan
    198 Callahan
  4. Jonathan Eric Rosenberg
    519 Rosenberg
  5. Chung-Han   Lee
    157 Lee
  6. Samuel Aaron Funt
    140 Funt
  7. Min Yuen   Teo
    105 Teo
  8. Jose Mauricio Mota
    13 Mota
  9. Karissa A. Whiting
    50 Whiting
  10. Han Li
    3 Li